RSV Immunization Resources
General Information for Providers
- RSV Immunization Information (CDC)
- RSV Immunization FAQs
- Updated Guidance for Healthcare Providers on Increased Supply of Nirsevimab to Protect Young Children from Severe Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season
- RSV Trends in the United States (CDC)
- VFC Enrollment Checklist for Birthing/Pediatric Hospitals
- RSV Vaccine Fact Sheet: Abrysvo™, Arexvy
- RSV Immunization Fact Sheet: Nirsevimab (Beyfortus™)
- Respiratory Disease Immunization Timing for Children
Infants and Children
- Nirsevimab Standing Orders (IAC)
- Nirsevimab (Beyfortus) Guide to Prevent Severe RSV in Infants and Toddlers
- Nirsevimab Guidance (CDC)
- Clinical Guidance to Prevent RSV Disease in Infants Webinar (CDC)
- Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
- Template Parent Portal and Robocall Messages for Infant RSV Immunization
- ACIP and AAP Recommendations for the Use of the Monoclonal Antibody Nirsevimab for the Prevention of RSV Disease (8/15/23)
- Nirsevimab Frequently Asked Questions (AAP)
- Beyfortus (Nirsevimab) Product Insert (FDA)
- CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth (Press Release)
Pregnancy
- Administer RSV Vaccine to Your Pregnant Patients – Shortage of Alternative (Nirsevimab) for Infants
- Template Patient Portal and Robocall Messages for Prenatal RSV Vaccine
- Clinical Guidance: RSV Vaccination for Pregnant People (CDC)
- Maternal RSV Vaccination Practice Advisory (ACOG)
- Use of Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023.
Older Adults
- Clinical Guidance: RSV Vaccination for 60+ (CDC)
- Shared Clinical Decision-Making Guidance Flyer for RSV Vaccine (CDC)
- Frequently Asked Questions About RSV Vaccine for Adults (CDC)
- Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 (CDC)
- New RSV Vaccines for Adults: General Information and Clinical Guidance (CDC Webinar 8/30/23)
- Product Inserts for ABRYSVO and AREXVY (FDA)
Patient Resources
- RSV Communications Toolkit
- Fall-Winter 2024 Immunizations Infographic | Spanish
- RSV Vaccine Information Statements (VIS) in Multiple Languages
- Nirsevimab Immunization Information Statements in Multiple Languages